Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection

…, S Zhang, Y Xu, LE Silberstein, T Cheng, F Ma… - Nature …, 2020 - nature.com
The full neutrophil heterogeneity and differentiation landscape remains incompletely characterized.
Here, we profiled >25,000 differentiating and mature mouse neutrophils using single-…

Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro

…, A Ségaliny, M Riazifar, V Pham, MA Digman… - Cellular and molecular …, 2016 - Springer
The delivery of therapeutics to the central nervous system remains a major challenge in part
due to the presence of the blood–brain barrier (BBB). Recently, cell-derived vesicles, …

Enhanced therapeutic effects of mesenchymal stem cell-derived exosomes with an injectable hydrogel for hindlimb ischemia treatment

…, Q Zhao, Z Guo, Z Han, N Liu, F Ma… - … applied materials & …, 2018 - ACS Publications
Mesenchymal stem cell (MSC)-derived exosomes have been recognized as new candidates
for cell-free treatment of various diseases. However, maintaining the retention and stability …

[HTML][HTML] Heterogeneity of neutrophils in cancer: one size does not fit all

…, Q Zhang, L Lu, C Xu, J Li, J Zha, F Ma… - Cancer Biology & …, 2022 - ncbi.nlm.nih.gov
Neutrophils play an essential role in the defense against bacterial infections and orchestrate
both the innate and adaptive immune responses. With their abundant numbers, diverse …

The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics

X Zhang, R Guo, H Kambara, F Ma… - Current opinion in …, 2019 - journals.lww.com
Neutrophil homeostasis, migration, and recruitment must be precisely regulated. The CXCR2
signaling pathway is a potential target for modifying neutrophil dynamics in inflammatory …

p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells

K Tian, S Yang, Q Ren, Z Han, S Lu, F Ma… - Cellular Physiology and …, 2011 - karger.com
Background/Aims: Mesenchymal stem cells (MSCs) have been implicated in antitumor
therapy for hematopoietic and non-hematopoietic tumors. Cell-contact and soluble factors are …

[HTML][HTML] Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages

…, N Liu, C Zhang, X Zhang, H Yu, L Zhao, F Ma… - Nature …, 2021 - nature.com
Candida albicans is the most common cause of fungal sepsis. Inhibition of inflammasome
activity confers resistance to polymicrobial and LPS-induced sepsis; however, inflammasome …

[HTML][HTML] VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity

…, Y Chi, F Ma, Z Li, S Yang, B Song, J Cui, T Ma… - Stem cell research & …, 2016 - Springer
Introduction Mesenchymal stem cells (MSCs) represent a heterogeneous cell population that
is promising for regenerative medicine. The present study was designed to assess whether …

Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis

…, V Pham, L Liu, M Riazifar, EJ Pone, SX Zhang, F Ma… - Biomaterials, 2016 - Elsevier
Systemic administration of mesenchymal stem cells (MSCs) affords the potential to ameliorate
the symptoms of Multiple Sclerosis (MS) in both preclinical and clinical studies. However, …

[HTML][HTML] Differential gene expression profile associated with the abnormality of bone marrow mesenchymal stem cells in aplastic anemia

J Li, S Yang, S Lu, H Zhao, J Feng, W Li, F Ma, Q Ren… - PLoS …, 2012 - journals.plos.org
Aplastic anemia (AA) is generally considered as an immune-mediated bone marrow failure
syndrome with defective hematopoietic stem cells (HSCs) and marrow microenvironment. …